(Q73245714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

[Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

interstitial lung disease

2 November 2019

main subject

1 reference

I Marie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Lévesque

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Dominique

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Y Hatron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U Michon-Pasturel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Remy-Jardin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Courtois

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1004-1016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

Clinical features, pathogenic mechanisms, and new developments in the treatment of systemic sclerosis.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

[Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

[Involvement of the small intestine in systemic scleroderma]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Scleroderma. Clinical problems. The lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Isolated diffusing capacity reduction in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

The relationship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

The lungs in systemic sclerosis (scleroderma): a review and new information

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary involvement in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Systemic scleroderma, A clinical study of 727 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Progressive Systemic Sclerosis Sine Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

[Primary pulmonary hypertension: a rare but often fatal complication of Crest syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Diffusing capacity of the lung and nifedipine in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Serological markers in progressive systemic sclerosis: clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Antinuclear antibodies associated with pulmonary involvement in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Antiendothelial Cell Antibodies: Useful Markers of Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Esophageal Motility and Pulmonary Function in Progressive Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Epidemiology of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Cardiopulmonary manifestations of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

An epidemiological study of scleroderma in the West Midlands

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Endobronchial telangiectasias and hemoptysis in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Small airways in progressive systemic sclerosis (PSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Structural features of interstitial lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Large cystic lesions of the upper lobes of the lungs in two patients with CHEST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Systemic sclerosis: using high-resolution CT to detect lung disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Optimization of Computed Tomography Technique to Demonstrate the Fine Structure of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pulmonary function in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Serial pulmonary function tests in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Increase of pulmonary diffusing capacity in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Pathogenetic and clinical significance of fibroblast activation in scleroderma lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Interstitial Lung Disease of Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Endothelin-1 secretion by alveolar macrophages in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Treatment of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Clinical manifestations of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Epidemiology of Systemic Sclerosis (Scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Systemic sclerosis: is there a treatment yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

The effect of D-penicillamine on pulmonary findings in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2987081-2

7 January 2021

10.1016/S0248-8663(00)87081-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586439%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference